This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gray, P. B. Articles by Bhasin, S. Search for Related Content PubMed PubMed Citation Articles by Gray, P. B. Articles by Bhasin, S. Related Collections Male Endocrinology

Dose-Dependent Effects of Testosterone on Sexual Function, Mood, and Visuospatial Cognition in Older Men

Charles Drew University, Division of Endocrinology, Los Angeles, California 90059

Address all correspondence and requests for reprints to: Dr. Shalender Bhasin, University of California School of Medicine, Department of Endocrinology, Metabolism and Molecular Medicine, Charles Drew University of Medicine and Science, 1731 East 120th Street, Los Angeles, California 90059. E-mail: sbhasin{at}ucla.edu.

Context: The relationships between testosterone dose and its effects on sexual function, mood, and visuospatial cognition are poorly understood.

Objective: To elucidate testosterone dose-response relationships in older men, we examined the effects of graded testosterone doses on sexual function, mood, and visuospatial cognition in healthy, older men (age, 60–75 yr).

Setting: This study was performed at the General Clinical Research Center.

Intervention/Methods: Subjects each received a long-acting GnRH agonist to suppress endogenous testosterone production and were randomized to receive one of five doses (25, 50, 125, 300, and 600 mg) of testosterone enanthate weekly for 20 wk. Questionnaires were used to evaluate sexual function. Scores for overall sexual function as well as subcomponents of sexual function (libido, sexual activity, and erectile function) were calculated.

Results: Changes in overall sexual function (P = 0.003) and waking erections (P = 0.024) differed by dose. An interaction between libido and being sexually active was observed, such that libido changed by testosterone dose only among men who reported being sexually active at the beginning of the study (P = 0.009). Men’s log-transformed free testosterone levels during treatment were positively correlated with overall sexual function (P = 0.001), waking erections (P = 0.040), spontaneous erections (P = 0.047), and libido (P = 0.027), but not with intercourse frequency (P = 0.428) or masturbation frequency (P = 0.814). No effects of testosterone dose were observed on two measures of mood: Hamilton’s Depression Inventory (P = 0.359) and Young’s Mania Scale (P = 0.851). The number of trials completed on a computer-based test of visuospatial cognition differed by dose (P = 0.042), but the number of squares correctly completed on this task did not differ by dose (P = 0.159).

Conclusions: Different aspects of male behavior respond differently to testosterone. When considered together with previous data from young men, these data indicate that testosterone dose-response relationships for sexual function and visuospatial cognition differ in older and young men.

This article has been cited by other articles:

				X. Millet, N. Raoux, N. Le Carret, J. Bouisson, J.-F. Dartigues, and H. Amieva Gender-related Differences in Visuospatial Memory Persist in Alzheimer's Disease Arch Clin Neuropsychol, November 3, 2009; (2009) acp086v1. [Abstract] [Full Text] [PDF]

				M Ebinger, C Sievers, D Ivan, H. Schneider, and G. Stalla Is there a neuroendocrinological rationale for testosterone as a therapeutic option in depression? J Psychopharmacol, September 1, 2009; 23(7): 841 - 853. [Abstract] [PDF]

				G. E. Krassas, K. Tziomalos, F. Papadopoulou, N. Pontikides, and P. Perros Erectile Dysfunction in Patients with Hyper- and Hypothyroidism: How Common and Should We Treat? J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1815 - 1819. [Abstract] [Full Text] [PDF]

				M. Wald, M. Miner, and A. D. Seftel State of the Art Reviews: Male Menopause: Fact or Fiction? American Journal of Lifestyle Medicine, April 1, 2008; 2(2): 132 - 141. [Abstract] [PDF]

				C. Vaughan, F. C. Goldstein, and J. L. Tenover Exogenous Testosterone Alone or With Finasteride Does Not Improve Measurements of Cognition in Healthy Older Men With Low Serum Testosterone J Androl, November 1, 2007; 28(6): 875 - 882. [Abstract] [Full Text] [PDF]

				M. Zitzmann, S. Faber, and E. Nieschlag Association of Specific Symptoms and Metabolic Risks with Serum Testosterone in Older Men J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4335 - 4343. [Abstract] [Full Text] [PDF]

				T. G. Travison, J. E. Morley, A. B. Araujo, A. B. O'Donnell, and J. B. McKinlay The Relationship between Libido and Testosterone Levels in Aging Men J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2509 - 2513. [Abstract] [Full Text] [PDF]

				A. Armagan, N. N. Kim, I. Goldstein, and A. M. Traish Dose-Response Relationship Between Testosterone and Erectile Function: Evidence for the Existence of a Critical Threshold J Androl, July 1, 2006; 27(4): 517 - 526. [Abstract] [Full Text] [PDF]